atomo HIV Self Test – coming soon
Self-testing is increasingly recognised for its potential to positively impact HIV detection rates. HIV self-testing (HIVST) enables individuals to test themselves in private. The greater convenience and discretion offered by HIVST means it can have a role to play in reaching previously undiagnosed, hard-to-reach and at-risk groups; helping to achieve the first ’90’ of the ambitious UNAIDS 90-90-90 target, to have 90% of people living with HIV diagnosed by 2020.
Atomo Diagnostics has been working with researchers, HIV charities and frontline healthcare professionals in countries with high HIV infection rates to develop an HIV self-test solution that truly meets the needs of lay users.
Recognised internationally for its commitment to user-centred design, Atomo has developed a convenient, all-in-one self-test solution that builds on the reliability, safety and best-in-class usability of its multi-award winning AtomoRapid HIV professional use test product.
The atomo HIV Self Test is set to launch in key markets during 2017.